Modus Therapeutics Holding AB (publ) (MODTX.ST)
SEK 1.89
(-5.04%)
SEK 1.89
(-5.04%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -16.68 Million | -21.72 Million | -16.07 Million | -7.23 Million | -43.89 Million | -40.06 Million |
| Net Income | -17.89 Million | -18 Million | -20.69 Million | -6.02 Million | -43.57 Million | -49.65 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -286 Thousand | -3.71 Million | 4.61 Million | -1.21 Million | -4.32 Million | 9.59 Million |
| Other non-cash items | 1.78 Million | 4.03 Million | -1000.00 | 1000.00 | 3.99 Million | -9.59 Million |
| Investing Cash Flow | - | - | -50 Thousand | - | -16 Thousand | -54 Thousand |
| Investments in PPE | - | - | - | - | -16 Thousand | -54 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -50 Thousand | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -50 Thousand | - | -16 Thousand | -54 Thousand |
| Financing Cash Flow | 25.32 Million | 11.5 Million | 29.43 Million | 13.2 Million | 3.5 Million | 73.82 Million |
| Debt repayment | -7 Million | -11.5 Million | - | -10.2 Million | -2.5 Million | -43.82 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 18.32 Million | - | 33.12 Million | 3 Million | 1.05 Million | 29.99 Million |
| Other Financing Activities | 25.32 Million | 23 Million | -3.69 Million | 20.4 Million | 4.95 Million | 73.82 Million |
| Accounts receivables | -133 Thousand | -304 Thousand | -347 Thousand | 528 Thousand | 503 Thousand | -104 Thousand |
| Accounts payables | -153 Thousand | -3.41 Million | 4.96 Million | -1.74 Million | -4.82 Million | 9.69 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -153 Thousand | -3.41 Million | 4.96 Million | -1.74 Million | -4.82 Million | 9.69 Million |
| Cash at beginning of period | 10.42 Million | 20.64 Million | 7.34 Million | 1.37 Million | 45.79 Million | 12.08 Million |
| Cash at end of period | 19.06 Million | 10.42 Million | 20.64 Million | 7.34 Million | 1.37 Million | 45.79 Million |
| Capital Expenditure | - | - | - | - | -16 Thousand | -54 Thousand |
| Effect of forex changes on cash | - | - | - | - | -4 Million | - |
| Net cash flow / Change in cash | 8.63 Million | -10.22 Million | 13.3 Million | 5.96 Million | -44.41 Million | 33.71 Million |
| Free Cash Flow | -16.68 Million | -21.72 Million | -16.07 Million | -7.23 Million | -43.91 Million | -40.11 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.8 Million | -3.19 Million | -4.06 Million | -17.89 Million | -2.45 Million | -4.36 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.31 Million | -560 Thousand | 643 Thousand | -286 Thousand | -500 Thousand | -98 Thousand |
| Other non-cash items | 1.00 | - | 297.99 Thousand | 1.78 Million | 1000.00 | 196 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | 18.32 Million | 25.32 Million | 2 Million | 2.5 Million |
| Debt repayment | - | - | - | -7 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 18.32 Million | - | - |
| Other Financing Activities | - | - | 18.32 Thousand | 25.32 Million | 2000.00 | 2.5 Million |
| Accounts receivables | - | - | -133.00 | -133 Thousand | - | - |
| Accounts payables | - | - | - | -153 Thousand | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1313.00 | -560.00 | 776.00 | -153 Thousand | -500.00 | 98.00 |
| Cash at beginning of period | 15.39 Million | 19.06 Million | 3.86 Million | 10.42 Million | 4.82 Million | 6.58 Million |
| Cash at end of period | 11.97 Million | 15.39 Million | 19.06 Million | 19.06 Million | 3.86 Million | 4.82 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -3.42 Million | -3.66 Million | 15.19 Million | 8.63 Million | -955 Thousand | -1.76 Million |
| Free Cash Flow | -3.42 Million | -3.66 Million | -3.12 Million | -16.68 Million | -2.95 Million | -4.26 Million |
DGII
SBHGF
6170
688037
6888
EDUCOMP